BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23084660)

  • 1. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
    Thaler J; Preusser M; Ay C; Kaider A; Marosi C; Zielinski C; Pabinger I; Hainfellner JA
    Thromb Res; 2013 Feb; 131(2):162-5. PubMed ID: 23084660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
    Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
    Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in brain tumors.
    Jo JT; Schiff D; Perry JR
    Semin Thromb Hemost; 2014 Apr; 40(3):325-31. PubMed ID: 24599439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
    Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
    J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
    Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
    Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and survival in patients with high-grade glioma.
    Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
    Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.
    Riedl J; Preusser M; Nazari PM; Posch F; Panzer S; Marosi C; Birner P; Thaler J; Brostjan C; Lötsch D; Berger W; Hainfellner JA; Pabinger I; Ay C
    Blood; 2017 Mar; 129(13):1831-1839. PubMed ID: 28073783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer.
    Cohen JG; Prendergast E; Geddings JE; Walts AE; Agadjanian H; Hisada Y; Karlan BY; Mackman N; Walsh CS
    Gynecol Oncol; 2017 Jul; 146(1):146-152. PubMed ID: 28501328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
    Holst AG; Jensen G; Prescott E
    Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tissue factor in glioma.
    Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
    Noshuyo Byori; 1996 Nov; 13(2):115-8. PubMed ID: 8958516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.
    Mir Seyed Nazari P; Riedl J; Preusser M; Posch F; Thaler J; Marosi C; Birner P; Ricken G; Hainfellner JA; Pabinger I; Ay C
    J Thromb Haemost; 2018 Jun; 16(6):1121-1127. PubMed ID: 29676036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
    Königsbrügge O; Pabinger I; Ay C
    Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
    Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.